Nora Kramkimel

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

18F-fluorodeoxyglucose PET/CT uptake characteristics in immune checkpoint inhibitor-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica.

18F-fluorodeoxyglucose PET/CT uptake characteristics in immune checkpoint inhibitor-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica.

Journal: Rheumatology (Oxford, England)

Published: December 10, 2025

Melanoma: Systemic treatments (part 2)

Melanoma: Systemic treatments (part 2)

Journal: Annales de chirurgie plastique et esthetique

Published: November 13, 2025

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma.

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma.

Journal: Cancer chemotherapy and pharmacology

Published: November 06, 2025

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Journal: The oncologist

Published: October 15, 2025

IL6 blockade: an effective approach in steroid-refractory immune checkpoint inhibitor-related neuropathies requiring ICI rechallenge-case report.

IL6 blockade: an effective approach in steroid-refractory immune checkpoint inhibitor-related neuropathies requiring ICI rechallenge-case report.

Journal: ESMO open

Published: July 21, 2025

Continuous Intrathecal Infusion of Nivolumab in Advanced Melanoma With Concomitant Leptomeningeal Disease: Efficacy, Safety, and Pharmacokinetics.

Continuous Intrathecal Infusion of Nivolumab in Advanced Melanoma With Concomitant Leptomeningeal Disease: Efficacy, Safety, and Pharmacokinetics.

Journal: Neurosurgery

Published: January 07, 2025

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Journal: The British journal of dermatology

Published: December 10, 2024

Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.

Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.

Journal: European journal of dermatology : EJD

Published: March 11, 2024

Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.

Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.

Journal: American journal of hematology

Published: January 21, 2024

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).

Journal: The oncologist

Published: December 17, 2023

Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.

Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 26, 2023

Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.

Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.

Journal: British journal of cancer

Published: October 03, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026